HomeBVNKF • OTCMKTS
add
Bavarian Nordic A/S
Nakaraang pagsara
$26.89
Sakop ng araw
$27.41 - $27.41
Sakop ng taon
$18.72 - $46.05
Market cap
2.16B USD
Average na Volume
127.00
P/E ratio
-
Dividend yield
-
Primary exchange
CPH
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (DKK) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 1.36B | -0.95% |
Gastos sa pagpapatakbo | 486.03M | -22.90% |
Net na kita | 70.49M | 120.69% |
Net profit margin | 5.17 | 120.89% |
Kita sa bawat share | 0.90 | -67.86% |
EBITDA | 250.46M | -34.15% |
Aktuwal na % ng binabayarang buwis | 2.71% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (DKK) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 1.87B | 24.16% |
Kabuuang asset | 13.95B | 4.10% |
Kabuuang sagutin | 3.26B | -19.68% |
Kabuuang equity | 10.69B | — |
Natitirang share | 78.32M | — |
Presyo para makapag-book | 0.20 | — |
Return on assets | 1.66% | — |
Return on capital | 2.19% | — |
Cash Flow
Net change in cash
| (DKK) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 70.49M | 120.69% |
Cash mula sa mga operasyon | -71.63M | -123.41% |
Cash mula sa pag-invest | 150.15M | 249.75% |
Cash mula sa financing | 109.92M | 1,051.60% |
Net change in cash | 180.29M | -10.03% |
Malayang cash flow | -914.47M | -666.57% |
Tungkol
Bavarian Nordic A/S is a fully integrated biotechnology company focused on the development, manufacturing and commercialization of vaccines. The company is headquartered in Hellerup, Denmark, with manufacturing facilities in Kvistgård, Denmark and Thörishaus near Bern, Switzerland. The company has research and development facilities in Martinsried, Germany and San Diego, California, as well as offices in Zug, Switzerland, and Morrisville, North Carolina. The company uses viral vectors and virus-like particles in its research and development. Wikipedia
CEO
Itinatag
Hul 1, 1992
Website
Mga Empleyado
1,609
